Normal values for distortion product otoacoustic emissions in children: A study using primary levels previously demonstrated to be optimum for identification of hearing loss

Scandinavian Audiology, Supplement

Volumn 30, Issue 53, 2001, Pages 37-43

  Brook, L ^a   Trussell, J ^a   Hilton, K ^a   Forsyth, H ^a   Pizer, B ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Child; Distortion product otoacoustic emission; Hearing loss; Normal values

Indexed keywords

ADOLESCENT; AGE; AUDIOLOGY; CHILD; COCHLEA; CONFERENCE PAPER; DEVICE; DIAGNOSTIC VALUE; DISTORTION PRODUCT OTOACOUSTIC EMISSION; FEMALE; HEARING LOSS; HUMAN; HUMAN EXPERIMENT; MALE; MIDDLE EAR DISEASE; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; ARTICLE; CROSS-SECTIONAL STUDY; HOSPITALIZATION; METHODOLOGY; NOISE; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PHYSIOLOGY; REFERENCE VALUE; SPONTANEOUS OTOACOUSTIC EMISSION;

AGE FACTORS; AUDIOMETRY, PURE-TONE; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; NOISE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX;

EID: 0034744014     PISSN: 01078593     EISSN: None     Source Type: Journal    
DOI: 10.1080/010503901750166628     Document Type: Conference Paper

References (15)

1. Bright KE. Spontaneous otoacoustic emissions. In: Robinette MS, Glattke TJ, eds. Otoacoustic emissions - clinical applications. New York: Thieme, 1997.
2. Brown AM, Sheppard SL, Russell PT. Acoustic distortion products from the ears of term infants and young adults using low stimulus levels. Br J Audiol 1994;28:273-80.
3. Dorn PA, Piskorski P, Keefe DH, et al. On the existence of an age/threshold/frequency interaction in distortion product otoacoustic emissions. J Acoust Soc Am 1998;104:964-71.
4. Glattke TJ, Robinette MS. Transient evoked otoacoustic emissions. In: Robinette MS, Glattke TJ, eds. Otoacoustic emissions - clinical applications. New York: Thieme, 1997.
5. Gorga MP, Stover L, Neely ST. The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements. J Acoust Soc Am 1996;100:968-77.
6. He NJ, Schmiedt RA. Fine structure of the 2f1-f2 acoustic distortion product: changes with primary level. J Acoust Soc Am 1995;94:2659-69.
7. Kemp D. Otoacoustic emissions in perspective. In: Robinette MS, Glattke TJ, eds. Otoacoustic emissions - clinical applications. New York, Thieme, 1997.
8. Kimberley BP, Brown DK, Allen JB. Distortion product otoacoustic emissions and sensorineural hearing loss. In: Robinette MS, Glattke TJ, eds. Otoacoustic emissions - clinical applications. New York, Thieme, 1997.
9. Lonsbury-Martin BL, Harris FP, Stagner BB, et al. Distortion product emissions in humans I: Basic properties in normally hearing subjects. Ann Otol Rhinol Laryngol 1990;99:3-14.
10. Lonsbury-Martin BL, McCoy MJ, Whitehead ML, Martin GK. Clinical testing of distortion product otoacoustic emissions. Ear Hear 1993;1:11-22
11. Lonsbury-Martin BL, Martin GK, Whitehead ML. Distortion product otoacoustic emissions. In: Robinette MS, Glattke TJ, eds. Otoacoustic emissions - clinical applications. New York, Thieme, 1997.
12. Popelka GR, Osterhammel PA, Nielsen LH, Rasmussen AN. Growth of distortion product otoacoustic emissions with primary-tone level in humans. Hear Res 1993;71:12-22.
13. Prieve BA, Fitzgerald TS, Schulte LE, Kemp DT. Basic characteristics of distortion product otoacoustic emissions in infant and children. J Acoust Soc Am 1997;102: 2871-9.
14. Stover L, Gorga MP, Neely ST, Montoya D. Toward optimising the clinical utility of distortion product otoacoustic emission measurements. J Acoust Soc Am 1996;100:956-67.
15. Widen JE. Evoked ototoacoustic emissions in evaluating children. In: Robinette MS, Glattke TJ, eds. Otoacoustic emissions - clinical applications. New York, Thieme, 1997.